Literature DB >> 21160049

Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.

John J Miles1, Duangtawan Thammanichanond, Sarah Moneer, Usha K Nivarthi, Lars Kjer-Nielsen, Samantha L Tracy, Campbell K Aitken, Rebekah M Brennan, Weiguang Zeng, Louise Marquart, David Jackson, Scott R Burrows, David S Bowden, Joseph Torresi, Margaret Hellard, Jamie Rossjohn, James McCluskey, Mandvi Bharadwaj.   

Abstract

Hepatitis C virus (HCV) infection causes significant morbidity and mortality worldwide. T cells play a central role in HCV clearance; however, there is currently little understanding of whether the disease outcome in HCV infection is influenced by the choice of TCR repertoire. TCR repertoires used against two immunodominant HCV determinants--the highly polymorphic, HLA-B*0801 restricted (1395)HSKKKCDEL(1403) (HSK) and the comparatively conserved, HLA-A*0101-restricted, (1435)ATDALMTGY(1443) (ATD)--were analyzed in clearly defined cohorts of HLA-matched, HCV-infected individuals with persistent infection and HCV clearance. In comparison with ATD, TCR repertoire selected against HSK was more narrowly focused, supporting reports of mutational escape in this epitope, in persistent HCV infection. Notwithstanding the Ag-driven divergence, T cell repertoire selection against either Ag was comparable in subjects with diverse disease outcomes. Biased T cell repertoires were observed early in infection and were evident not only in persistently infected individuals but also in subjects with HCV clearance, suggesting that these are not exclusively characteristic of viral persistence. Comprehensive clonal analysis of Ag-specific T cells revealed widespread use of public TCRs displaying a high degree of predictability in TRBV/TRBJ gene usage, CDR3 length, and amino acid composition. These public TCRs were observed against both ATD and HSK and were shared across diverse disease outcomes. Collectively, these observations indicate that repertoire diversity rather than particular Vβ segments are better associated with HCV persistence/clearance in humans. Notably, many of the anti-HCV TCRs switched TRBV and TRBJ genes around a conserved, N nucleotide-encoded CDR3 core, revealing TCR sequence mosaicism as a potential host mechanism to combat this highly variant virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160049     DOI: 10.4049/jimmunol.1003167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.

Authors:  Corey Smith; Dillon Corvino; Leone Beagley; Sweera Rehan; Michelle A Neller; Pauline Crooks; Katherine K Matthews; Matthew Solomon; Laetitia Le Texier; Scott Campbell; Ross S Francis; Daniel Chambers; Rajiv Khanna
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

2.  CD28neg. T lymphocytes of a melanoma patient harbor tumor immunity and a high frequency of germline-encoded and public TCRs.

Authors:  Hisayoshi Hashimoto; Marco Sterk; Karin Schilbach
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

3.  HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.

Authors:  Rebecca A Porritt; Lisa Paschold; Magali Noval Rivas; Mary Hongying Cheng; Lael M Yonker; Harsha Chandnani; Merrick Lopez; Donjete Simnica; Christoph Schultheiß; Chintda Santiskulvong; Jennifer Van Eyk; John K McCormick; Alessio Fasano; Ivet Bahar; Mascha Binder; Moshe Arditi
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

4.  Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age.

Authors:  Anna Gil; Maryam B Yassai; Yuri N Naumov; Liisa K Selin
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

5.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

6.  T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  S Russi; G Lauletta; G Serviddio; S Sansonno; V Conteduca; L Sansonno; V De Re; D Sansonno
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

7.  Targeted reconstruction of T cell receptor sequence from single cell RNA-seq links CDR3 length to T cell differentiation state.

Authors:  Shaked Afik; Kathleen B Yates; Kevin Bi; Samuel Darko; Jernej Godec; Ulrike Gerdemann; Leo Swadling; Daniel C Douek; Paul Klenerman; Eleanor J Barnes; Arlene H Sharpe; W Nicholas Haining; Nir Yosef
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

8.  High-resolution description of antibody heavy-chain repertoires in humans.

Authors:  Ramy Arnaout; William Lee; Patrick Cahill; Tracey Honan; Todd Sparrow; Michael Weiand; Chad Nusbaum; Klaus Rajewsky; Sergei B Koralov
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

9.  Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.

Authors:  Anna Pasetto; Lars Frelin; Anette Brass; Anila Yasmeen; Sarene Koh; Volker Lohmann; Ralf Bartenschlager; Isabelle Magalhaes; Markus Maeurer; Matti Sällberg; Margaret Chen
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

10.  Expansion of Unique Hepatitis C Virus-Specific Public CD8+ T Cell Clonotypes during Acute Infection and Reinfection.

Authors:  Sabrina Mazouz; Maude Boisvert; Mohamed S Abdel-Hakeem; Omar Khedr; Julie Bruneau; Naglaa H Shoukry
Journal:  J Immunol       Date:  2021-08-02       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.